Cargando…
Feasibility of a Microarray-Based Point-of-Care CYP2C19 Genotyping Test for Predicting Clopidogrel On-Treatment Platelet Reactivity
Clopidogrel is a prodrug which is converted into active metabolite by cytochrome P450 isoenzyme, CYP2C19. Numerous polymorphisms of CYP2C19 are reported, and a strong link exists between loss-of-function (LOF) or gain-of-function polymorphisms, clopidogrel metabolism, and clinical outcome. Hence, a...
Autores principales: | Chae, Hyojin, Kim, Myungshin, Koh, Yoon-Seok, Hwang, Byung-Hee, Kang, Min-Kyu, Kim, Yonggoo, Park, Hae-il, Chang, Kiyuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625605/ https://www.ncbi.nlm.nih.gov/pubmed/23607088 http://dx.doi.org/10.1155/2013/154073 |
Ejemplares similares
-
Molecular analysis of the PAX6 gene for congenital aniridia in the Korean population: Identification of four novel mutations
por: Park, Shin Hae, et al.
Publicado: (2012) -
Molecular analysis of the CHST6 gene in Korean patients with macular corneal dystrophy: Identification of three novel mutations
por: Park, Shin Hae, et al.
Publicado: (2015) -
Identification of small marker chromosomes using microarray comparative genomic hybridization and multicolor fluorescent in situ hybridization
por: Jang, Woori, et al.
Publicado: (2016) -
X-Linked Spondyloepiphyseal Dysplasia Tarda: Identification of a TRAPPC2 Mutation in a Korean Pedigree
por: Ryu, Hyejin, et al.
Publicado: (2012) -
The CYP2C19 genotypes and its effect on clopidogrel as an anti-platelet drug among the Arab population
por: Alkattan, Abdullah, et al.
Publicado: (2021)